Skip to main content
Premium Trial:

Request an Annual Quote

BioInform's Licensing Roundup: October's Software, Database, and IT Deals

Premium
BioInform's Licensing Roundup:
October's Software, Database, and IT Deals
Company Product Licensees
Software Agilent Technologies Agilent GeneSpring GX, Agilent CGH Analytics, Agilent Chip Analytics, GeneSpring GT National Cancer Institute
BioAnalyte ProTrawler Intertek Caleb Brett
Cerno Bioscience Massworks The Chinese Academy of Sciences, Egret Pharma
Genedata Expressionist, Phylosopher Wyeth Pharmaceuticals
GeneGo MetaCore Robert S. Dow Neurobiology Laboratories
Geneva Bioinformatics Phenyx ProteoRed (Spain's national proteomics network), University of Washington (Goodlett lab)
Ingenuity Systems Ingenuity Pathway Analysis AstraZeneca
LabVantage Sapphire LIMS Roswell Park Cancer Institute
Simulations Plus ClassPharmer National Institute of Health Sciences (Japan)
Databases Biobase Proteome, Transfac National Institutes of Health (extension of existing license)
Inpharmatica Kinase SARfari knowledgebase Schering

Filed under

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.